A pilot study of Lewis-Y targeting Chimeric Antigen Receptor T-cells given in combination with Nivolumab in Lewis-Y expressing solid tumours.

Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2022
This article has no abstract
Epistemonikos ID: 7e140781d400f4ea0d8151dc4a370e3619b94b57
First added on: Mar 18, 2025